Morning Digest | Four militants behind J&K targeted killings shot dead; Covaxin trials in U.S. put on hold, and more

A select list of stories to read before you start your day

Four dead in Shopian shoot-out behind migrant killing: police

Four Lashkar-e-Taiba (LeT) militants, who were behind the recent targeted killings of non-locals, were killed in an operation in south Kashmir’s Shopian on Thursday. Three soldiers, on their way to the encounter site, were killed when their vehicle met with an accident.

U.S. FDA puts on hold Covaxin’s phase 2/3 clinical trials

The U.S. Food and Drug Administration (USFDA) has put on hold the phase 2/3 clinical trials of Bharat Biotech’s COVID-19 vaccine Covaxin in the U.S. Bharat Biotech’s partner in the U.S. Ocugen in a release said it was informed by the USFDA that its phase 2/3 immuno-bridging and broadening study for Covaxin (BBV152), OCU-002, had been placed on clinical hold.

Twitter CEO tells employees company not ‘held hostage’ by Elon Musk offer: source

Twitter Chief Executive Officer Parag Agrawal sought to reassure employees during an all-hands meeting on April 14 that the company was not being “held hostage” by news of Elon Musk’s offer to buy the company, a source familiar with the matter told Reuters.

‘Terror group’ founder arrested for threatening Meghalaya CM Conrad Sangma